Open Access Correction

Association of the germline TP53 R337H mutation with breast cancer in southern Brazil

Juliana G Assumpção1, Ana Luíza Seidinger1, Maria José Mastellato1, Raul C Ribeiro23, Gerard P Zambetti4, Ramapriya Ganti5, Kumar Srivastava6, Sheila Shurtleff5, Deqing Pei6, Luiz Carlos Zeferino7, Rozany M Dufloth8, Silvia Regina Brandalise1 and José Andres Yunes1*

Author Affiliations

1 Centro Infantil Boldrini, Campinas, Brazil

2 Department of Oncology, St. Jude Children's Research Hospital, Memphis, USA

3 International Outreach Program, St. Jude Children's Research Hospital, Memphis, USA

4 Department of Biochemistry, St. Jude Children's Research Hospital, Memphis, USA

5 Department of Pathology, St. Jude Children's Research Hospital, Memphis, USA

6 Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, USA

7 Universidade Estadual de Campinas, Campinas, Brazil

8 Universidade Federal de Santa Catarina, Florianópolis, Brazil

For all author emails, please log on.

BMC Cancer 2011, 11:152  doi:10.1186/1471-2407-11-152

Published: 26 April 2011

First paragraph (this article has no abstract)

Of the 123 patients included in our work [1], 44 were selected according to the following familial risk history criteria: early onset (less than 35 years of age); bilateral carcinoma; more than three cases of breast cancer and more than one case of ovarian cancer in the family; more than two first degree relatives involved; and male breast cancer. We regret that in the methods section of our manuscript [1], it was erroneously stated both that the number of patients with familial history was 45 and that the criteria used for their selection was: "had either more than three cases of breast cancer and more than one case of ovarian cancer in the family; or had more than two first-degree relatives with breast cancer; or had one case of male breast cancer" (only two out of these 44 patients would have fulfilled these criteria).